Percutaneous transjugular portosystemic shunt: Commentary on the technical aspects of this new procedure by Marx, M. Victoria & Williams, David M.
Vol. 15, No. 3, 1992 HEPATOLOGY Elsewhere 557 
rebleeding. The one patient who rebled in this study 
apparently had suboptimal reduction of portal pressure 
(from 38 to 18 mm Hg) and required stent expansion to 
lower the portosystemic gradient to 8 mm Hg. What 
percentage of patients in larger studies will achieve 
adequate portal decompression to prevent variceal re- 
bleeding? Will these figures compare favorably with the 
effectiveness of surgical shunts (5)? What will be the 
duration of shunt patency after TIPS? The mean 
follow-up in this study was only 5 mo, and two patients 
required balloon angioplasty of the stent to provide 
better decompression during this follow-up. If the 
duration of TIPS patency is shorter than that achieved 
by surgical shunting or if prolonged patency requires 
frequent interval venous portography and angioplasty, 
the procedure may be less applicable than anticipated. 
The final issues to be determined are those of 
long-term complications and the relative cost of TIPS 
compared with other alternatives. The authors report 
that no patient had severe hepatic encephalopathy 
develop after TIPS, although we are not told whether 
milder forms of encephalopathy occurred. One would 
expect that once adequate portal decompression is 
achieved, encephalopathy will occur at a similar rate to 
that after surgical shunting (6). Finally, TIPS will have 
to be compared with medical therapy and sclerotherapy. 
Most clinicians use sclerotherapy as a first-line therapy 
for the prevention of variceal rebleeding and reserve 
surgical shunts for sclerotherapy failures, noncompliant 
patients or patients living in geographically remote 
areas with limited access to medical facilities (7). We 
must also consider what effect TIPS will have on 
subsequent liver transplantation. Presumably avoiding 
dissection of the porta hepatis will reduce the complexity 
of subsequent liver transplantation and thereby may 
reduce postoperative mortality and morbidity rates (8). 
TIPS is an exciting new nonsurgical technique for 
managing variceal hemorrhage caused by portal hyper- 
tension. It is unlikely that this procedure will entirely 
replace other available techniques; rather, it will most 
likely be indicated for the prevention of rebleeding in 
selected groups of patients. Definition of these patient 
groups awaits results from larger studies that are 
needed to establish the safety and efficacy of TIPS 
compared with more well-established techniques for 
managing variceal hemorrhage. 
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PERCUTANEOUS TRANSJUGULAR 
PORTOSYSTEMIC SHUNT: COMMENTARY ON THE 
TECHNICAL ASPECTS OF THIS NEW PROCEDURE 
COMMENTS 
Transjugular intrahepatic portosystemic shunt 
(TIPS) is an exciting new interventional procedure for 
the treatment of portal hypertension that is being 
investigated at several institutions, including the Miami 
Vascular Institute. In its current stage of development, 
TIPS should be performed only in a setting that is as 
ideal as is possible. Angiographic laboratory prerequi- 
sites for the performance of this procedure include 
high-resolution C-arm fluoroscopy, digital subtraction 
angiographic capability, and equipment and personnel 
to provide the patient with adequate analgesia, sedation 
and monitoring during the procedure. High-quality 
ultrasound should be available. Operator skills must 
include experience with standard catheter-guidewire 
manipulations and angioplasty techniques and famil- 
iarity with intrahepatic anatomy and stent deployment 
protocols. 
TIPS presents several technical challenges to the 
experienced interventionist that were not detailed in 
the recent JAMA article by Zemel et al. Transjugular, 
fluoroscopically guided needle puncture of a central 
portal vein branch by way of a hepatic vein is a technique 
still in evolution. Several methods to assist in aiming the 
needle have been used, including transabdominal 
placement of a portal vein catheter, directing the 
puncture toward the expected location of the portal vein 
as demonstrated on previous computed tomography or 
arterial portography and directing the puncture toward 
the portal vein under a combination of fluoroscopic and 
ultrasound guidance. The first method requires a trans- 
abdominal puncture, a possible source of peritoneal 
hemorrhage. The latter two methods avo',d this possible 
complication but may require multiple intrahepatic 
needle passes with a 16-gauge needle - a possible source 
of intrahepatic pseudoaneurysm formation. After an 
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initial learning curve where they used a transhepatic 
portal vein catheter as a target, Zemel et al. have found 
the second method satisfactory and have had no com- 
plications relating to this step in the procedure. A 
determination of the technique that is most reliable and 
is associated with the fewest complications will come 
only with a larger patient population and longer 
follow-up. 
Advancement of angiographic catheters through cir- 
rhotic liver parenchyma and initial dilatation of the 
transhepatic shunt tract present a second challenge to 
the operator. The diseased liver is fibrotic and can be 
quite resistant to the passage of catheters. Experience 
with and creativity in the use of the wide variety of 
catheters and guidewires available to achieve this goal 
are necessary to ensure success. 
Choice and optimal deployment of the indwelling stent 
are the final, and perhaps most important, challenges 
presented to the operator performing TIPS. Two types of 
stents are currently undergoing investigation for this 
application in the United States: the Palmaz balloon 
expandable stent (Johnson and Johnson, Warren NJ) 
and the Wallstent (Schneider USA, Minneapolis MN). 
Zemel et al. confined their study to an evaluation of the 
Palmaz stent, which is rigid, relatively noncompressible 
in its expanded state and expandable over a wide range 
of luminal diameters. In contrast, the Wallstent is 
flexible but somewhat more compressible. With either 
choice, the stent(s) must cover the entire length of the 
shunt to minimize the risk of shunt stenosis and 
thrombosis. The anatomic and physiological consider- 
ations that exist to favor the use of one of these stents 
over the other is as yet unknown. More studies, such as 
this one with its protocol of using only one type of stent, 
and longer follow-up will be necessary to answer this 
question. 
The report by Zemel’s group represents progress in 
the development of TIPS as a method to treat portal 
hypertension. These investigators are to be congratu- 
lated for their work. They and others pursuing orga- 
nized clinical protocols to evaluate this procedure should 
be encouraged in their efforts. 
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